These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 26345890

  • 21. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.
    Mateos MV, Landgren O.
    Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254
    [Abstract] [Full Text] [Related]

  • 22. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL, Grosbois B, Bataille R.
    Cancer Res; 1999 Sep 15; 59(18):4546-50. PubMed ID: 10493504
    [Abstract] [Full Text] [Related]

  • 23. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.
    Walker BA, Wardell CP, Melchor L, Brioli A, Johnson DC, Kaiser MF, Mirabella F, Lopez-Corral L, Humphray S, Murray L, Ross M, Bentley D, Gutiérrez NC, Garcia-Sanz R, San Miguel J, Davies FE, Gonzalez D, Morgan GJ.
    Leukemia; 2014 Feb 15; 28(2):384-390. PubMed ID: 23817176
    [Abstract] [Full Text] [Related]

  • 24. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA, Desantis V, Di Marzo L, Craparotta I, Beltrame L, Marchini S, Annese T, Visino F, Arciuli M, Saltarella I, Lamanuzzi A, Solimando AG, Nico B, De Angelis M, Racanelli V, Mariggiò MA, Chiacchio R, Pizzuti M, Gallone A, Fumarulo R, D'Incalci M, Vacca A.
    J Pathol; 2019 Feb 15; 247(2):241-253. PubMed ID: 30357841
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal gammopathies of unknown significance and smoldering myeloma: Assessment and management of the elderly patients.
    González-Calle V, Mateos MV.
    Eur J Intern Med; 2018 Dec 15; 58():57-63. PubMed ID: 29907380
    [Abstract] [Full Text] [Related]

  • 26. Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
    Isola I, Brasó-Maristany F, Moreno DF, Mena MP, Oliver-Calders A, Paré L, Rodríguez-Lobato LG, Martin-Antonio B, Cibeira MT, Bladé J, Rosiñol L, Prat A, Lozano E, Fernández de Larrea C.
    Front Immunol; 2021 Dec 15; 12():792609. PubMed ID: 34880879
    [Abstract] [Full Text] [Related]

  • 27. [Smoldering multiple myeloma].
    Fouquet G, Guidez S, Herbaux C, Demarquette H, Leleu X.
    Rev Med Interne; 2014 Apr 15; 35(4):243-9. PubMed ID: 24050785
    [Abstract] [Full Text] [Related]

  • 28. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.
    Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M.
    Leuk Lymphoma; 2018 Jan 15; 59(1):178-186. PubMed ID: 28540748
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
    Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, Fenton JA, Hideshima T, Chauhan D, Tai IT, Robinson E, Auclair D, Rees K, Gonzalez D, Ashcroft AJ, Dasgupta R, Mitsiades C, Mitsiades N, Chen LB, Wong WH, Munshi NC, Morgan GJ, Anderson KC.
    Blood; 2003 Dec 15; 102(13):4504-11. PubMed ID: 12947006
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA.
    Int J Cancer; 2014 Nov 15; 135(10):2380-6. PubMed ID: 24706394
    [Abstract] [Full Text] [Related]

  • 35. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
    Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Zangari M, Dhodapkar M, Shaughnessy JD.
    Blood; 2007 Feb 15; 109(4):1692-700. PubMed ID: 17023574
    [Abstract] [Full Text] [Related]

  • 36. Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders.
    Lehners N, Ellert E, Xu J, Hillengass J, Leichsenring J, Stenzinger A, Goldschmidt H, Andrulis M, Raab MS.
    Leuk Lymphoma; 2018 Nov 15; 59(11):2660-2669. PubMed ID: 29616856
    [Abstract] [Full Text] [Related]

  • 37. Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
    Paiva B, Pérez-Andrés M, Vídriales MB, Almeida J, de las Heras N, Mateos MV, López-Corral L, Gutiérrez NC, Blanco J, Oriol A, Hernández MT, de Arriba F, de Coca AG, Terol MJ, de la Rubia J, González Y, Martín A, Sureda A, Schmidt-Hieber M, Schmitz A, Johnsen HE, Lahuerta JJ, Bladé J, San-Miguel JF, Orfao A, GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas), Myeloma Stem Cell Network (MSCNET).
    Leukemia; 2011 Apr 15; 25(4):697-706. PubMed ID: 21252988
    [Abstract] [Full Text] [Related]

  • 38. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR.
    Clin Cancer Res; 2002 Jul 15; 8(7):2210-6. PubMed ID: 12114422
    [Abstract] [Full Text] [Related]

  • 39. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches.
    Lagreca I, Riva G, Nasillo V, Barozzi P, Castelli I, Basso S, Bettelli F, Giusti D, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Pioli V, Colasante C, Vallerini D, Paolini A, Maccaferri M, Donatelli F, Forghieri F, Morselli M, Colaci E, Leonardi G, Marasca R, Potenza L, Manfredini R, Tagliafico E, Trenti T, Comoli P, Luppi M.
    Int J Mol Sci; 2022 May 08; 23(9):. PubMed ID: 35563634
    [Abstract] [Full Text] [Related]

  • 40. Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
    Oben B, Froyen G, Maclachlan KH, Leongamornlert D, Abascal F, Zheng-Lin B, Yellapantula V, Derkach A, Geerdens E, Diamond BT, Arijs I, Maes B, Vanhees K, Hultcrantz M, Manasanch EE, Kazandjian D, Lesokhin A, Dogan A, Zhang Y, Mikulasova A, Walker B, Morgan G, Campbell PJ, Landgren O, Rummens JL, Bolli N, Maura F.
    Nat Commun; 2021 Mar 25; 12(1):1861. PubMed ID: 33767199
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.